[Federal Register Volume 63, Number 38 (Thursday, February 26, 1998)]
[Notices]
[Page 9846]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-4869]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Cancer Institute Special Emphasis Panel (SEP) meeting:

    Name of SEP: Polyvalent Vaccine Phase III Trial--Stage VI--
Melanoma. Telephone Conference Call.
    Date: March 17, 1998.
    Time: 1 p.m. to Adjournment.
    Place: National Cancer Institute, Executive Plaza North, Room 
611C, 6130 Executive Boulevard, Bethesda, MD 20892-7403.
    Contact Person: John L. Meyer, Ph.D., Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 611C, 6130 Executive Boulevard, MSC 7403, Bethesda, MD 
20892-7403, Telephone: 301/496-7721.
    Purpose/Agenda: To review, discuss and evaluate grant 
applications.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: February 19, 1998.
LaVeen Ponds,
Acting Committee Management Officer, National Institutes of Health.
[FR Doc. 98-4869 Filed 2-25-98; 8:45 am]
BILLING CODE 4140-01-M